This inventor holds 0 USPTO granted patents, plus 5 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Chuangxing Guo: Innovator in Pharmaceutical Research
Introduction
Chuangxing Guo is a notable inventor based in the United States. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with therapeutic applications. Although he currently holds no patents, his work is influential in advancing medical science.
Latest Patents
Chuangxing Guo's latest patents include innovative compounds aimed at addressing various health issues. One of his notable inventions involves bicyclic compounds, which are disclosed for their potential use as analgesics. Additionally, he has worked on selective mTOR inhibitors, which are designed to treat diseases related to abnormal cell growth, including cancer and immune disorders. These compounds have broad therapeutic applications, targeting conditions such as cardiovascular disease, viral infections, inflammation, and neurological disorders.
Career Highlights
Chuangxing Guo is associated with Kalyra Pharmaceuticals, Inc., where he contributes to the development of groundbreaking pharmaceutical solutions. His expertise in synthesizing complex compounds positions him as a valuable asset in the research and development sector.
Collaborations
Chuangxing Guo collaborates with Youzhi Tong, enhancing the innovative capacity of their research team. Their combined efforts aim to push the boundaries of pharmaceutical science and improve patient outcomes.
Conclusion
Chuangxing Guo's work in pharmaceutical research exemplifies the spirit of innovation in the medical field. His contributions, particularly in the development of therapeutic compounds, hold promise for addressing significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile